| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Chief Financial Officer
1 company
Phillips Barclay A serves as a SVP, Chief Financial Officer at NVAX. Across recent SEC filings that breaks down to 7 buys and 2 sells. Those positions are worth an estimated $34K at current prices.
The biggest single holding is NVAX (~$34K) as SVP, Chief Financial Officer. Net of sales, the recent Form 4 record there shows accumulation of 10,013 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 31, 2017 | NVAX Novavax Inc | SVP, Chief Financial Officer | Buy | 2,057 | $0.89 | $1,830.73 | +5.6% | |
| May 11, 2017 | NVAX Novavax Inc | SVP, Chief Financial Officer | Buy | 25,000 | $0.84 | $20,950.00 | +215.3% | |
| Jan 31, 2017 | NVAX Novavax Inc | SVP, Chief Financial Officer | Buy | 1,633 | $1.12 | $1,828.96 | +16.4% | |
| Jul 31, 2016 | NVAX Novavax Inc | SVP, Chief Financial Officer | Buy | 422 | $4.29 | $1,810.38 | +4.4% | |
| Jan 31, 2016 | NVAX Novavax Inc | SVP, Chief Financial Officer | Buy | 405 | $4.38 | $1,773.90 | +4.4% | |
| Aug 20, 2015 | NVAX Novavax Inc | SVP, Chief Financial Officer | Sell | 28,656 | $13.06 | $374,323.37 | -75.8% | |
| Jul 31, 2015 | NVAX Novavax Inc | SVP, Chief Financial Officer | Buy | 764 | $2.28 | $1,741.92 | +2.1% | |
| Jan 31, 2015 | NVAX Novavax Inc | SVP, Chief Financial Officer | Buy | 8,388 | $2.28 | $19,124.64 | +29.3% |